INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3 | -62.5% | 7,655 | -52.1% | 0.00% | 0.0% |
Q2 2023 | $8 | -42.9% | 15,985 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $14 | 0.0% | 15,985 | +89.6% | 0.00% | -33.3% |
Q4 2022 | $14 | -99.9% | 8,430 | -33.3% | 0.00% | -40.0% |
Q3 2022 | $23,000 | -14.8% | 12,630 | 0.0% | 0.01% | -16.7% |
Q2 2022 | $27,000 | -38.6% | 12,630 | +2.7% | 0.01% | -25.0% |
Q1 2022 | $44,000 | 0.0% | 12,300 | +38.2% | 0.01% | 0.0% |
Q4 2021 | $44,000 | -48.2% | 8,900 | -25.2% | 0.01% | -46.7% |
Q3 2021 | $85,000 | -34.1% | 11,900 | -14.4% | 0.02% | -37.5% |
Q2 2021 | $129,000 | +18.3% | 13,900 | +18.8% | 0.02% | +14.3% |
Q1 2021 | $109,000 | -21.6% | 11,700 | -25.5% | 0.02% | -27.6% |
Q4 2020 | $139,000 | -23.6% | 15,700 | 0.0% | 0.03% | -31.0% |
Q3 2020 | $182,000 | -49.2% | 15,700 | +18.0% | 0.04% | -48.8% |
Q2 2020 | $358,000 | +306.8% | 13,300 | +12.8% | 0.08% | +241.7% |
Q1 2020 | $88,000 | +166.7% | 11,796 | +17.3% | 0.02% | +200.0% |
Q4 2019 | $33,000 | +57.1% | 10,057 | 0.0% | 0.01% | +33.3% |
Q3 2019 | $21,000 | – | 10,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Triatomic Management LP | 235,000 | $405,000 | 0.23% |
Green Alpha Advisors, LLC | 147,380 | $254,000 | 0.22% |
Financial Advocates Investment Management | 14,161 | $628,000 | 0.05% |
Virtus ETF Advisers LLC | 72,540 | $125,000 | 0.05% |
Cedar Brook Financial Partners, LLC | 88,750 | $153,094 | 0.05% |
Rafferty Asset Management, LLC | 2,363,189 | $4,077,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 352,721 | $608,000 | 0.04% |
CAXTON ASSOCIATES LP | 130,728 | $226,000 | 0.03% |
Keystone Financial Group | 74,058 | $128,000 | 0.03% |
Virtu Financial LLC | 130,829 | $226,000 | 0.02% |